nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—AOX1—Methotrexate—lymphatic system cancer	0.204	0.257	CbGbCtD
Ethinyl Estradiol—ABCB11—Vincristine—lymphatic system cancer	0.194	0.244	CbGbCtD
Ethinyl Estradiol—ABCC2—Vincristine—lymphatic system cancer	0.102	0.128	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—lymphatic system cancer	0.0617	0.0776	CbGbCtD
Ethinyl Estradiol—ABCB1—Mitoxantrone—lymphatic system cancer	0.0483	0.0607	CbGbCtD
Ethinyl Estradiol—CYP3A4—Cytarabine—lymphatic system cancer	0.042	0.0528	CbGbCtD
Ethinyl Estradiol—CYP3A4—Teniposide—lymphatic system cancer	0.0414	0.052	CbGbCtD
Ethinyl Estradiol—ABCB1—Vincristine—lymphatic system cancer	0.0332	0.0418	CbGbCtD
Ethinyl Estradiol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0289	0.0364	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—lymphatic system cancer	0.0201	0.0253	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vincristine—lymphatic system cancer	0.0199	0.025	CbGbCtD
Ethinyl Estradiol—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00143	0.00701	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Fludarabine—lymphatic system cancer	0.00139	0.00678	CcSEcCtD
Ethinyl Estradiol—Dysuria—Fludarabine—lymphatic system cancer	0.00135	0.0066	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00134	0.00656	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Carmustine—lymphatic system cancer	0.00133	0.00651	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Teniposide—lymphatic system cancer	0.00132	0.00646	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Teniposide—lymphatic system cancer	0.00131	0.00642	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00131	0.00641	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00127	0.0062	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00126	0.00616	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00126	0.00616	CcSEcCtD
Ethinyl Estradiol—Infection—Mechlorethamine—lymphatic system cancer	0.00126	0.00615	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00125	0.00611	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00125	0.00611	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00123	0.00601	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Fludarabine—lymphatic system cancer	0.00121	0.0059	CcSEcCtD
Ethinyl Estradiol—Alopecia—Teniposide—lymphatic system cancer	0.00116	0.00568	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Fludarabine—lymphatic system cancer	0.00116	0.00567	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Fludarabine—lymphatic system cancer	0.00115	0.00565	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00115	0.00562	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Fludarabine—lymphatic system cancer	0.00115	0.0056	CcSEcCtD
Ethinyl Estradiol—Vaginal discharge—Methotrexate—lymphatic system cancer	0.00112	0.00548	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Fludarabine—lymphatic system cancer	0.00111	0.00544	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00109	0.00534	CcSEcCtD
Ethinyl Estradiol—Embolism—Methotrexate—lymphatic system cancer	0.00106	0.00519	CcSEcCtD
Ethinyl Estradiol—Alopecia—Fludarabine—lymphatic system cancer	0.00102	0.00499	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Vincristine—lymphatic system cancer	0.00102	0.00499	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Fludarabine—lymphatic system cancer	0.00101	0.00491	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Bleomycin—lymphatic system cancer	0.000957	0.00468	CcSEcCtD
Ethinyl Estradiol—Oedema—Teniposide—lymphatic system cancer	0.000933	0.00456	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000933	0.00456	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000933	0.00456	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00093	0.00455	CcSEcCtD
Ethinyl Estradiol—Infection—Teniposide—lymphatic system cancer	0.000927	0.00453	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.000924	0.00452	CcSEcCtD
Ethinyl Estradiol—Malaise—Fludarabine—lymphatic system cancer	0.000906	0.00443	CcSEcCtD
Ethinyl Estradiol—Pruritus—Mechlorethamine—lymphatic system cancer	0.000896	0.00438	CcSEcCtD
Ethinyl Estradiol—Cough—Fludarabine—lymphatic system cancer	0.000877	0.00429	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000866	0.00424	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Bleomycin—lymphatic system cancer	0.000851	0.00416	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Bleomycin—lymphatic system cancer	0.000847	0.00414	CcSEcCtD
Ethinyl Estradiol—Discomfort—Fludarabine—lymphatic system cancer	0.000845	0.00413	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000842	0.00412	CcSEcCtD
Ethinyl Estradiol—Dysuria—Vincristine—lymphatic system cancer	0.000824	0.00403	CcSEcCtD
Ethinyl Estradiol—Depression—Carmustine—lymphatic system cancer	0.000821	0.00401	CcSEcCtD
Ethinyl Estradiol—Oedema—Fludarabine—lymphatic system cancer	0.00082	0.00401	CcSEcCtD
Ethinyl Estradiol—Infection—Fludarabine—lymphatic system cancer	0.000815	0.00398	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000807	0.00395	CcSEcCtD
Ethinyl Estradiol—Vomiting—Mechlorethamine—lymphatic system cancer	0.000805	0.00394	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000804	0.00393	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Carmustine—lymphatic system cancer	0.0008	0.00391	CcSEcCtD
Ethinyl Estradiol—Rash—Mechlorethamine—lymphatic system cancer	0.000798	0.0039	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.000798	0.0039	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000797	0.0039	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Vincristine—lymphatic system cancer	0.000797	0.0039	CcSEcCtD
Ethinyl Estradiol—Depression—Vincristine—lymphatic system cancer	0.000783	0.00383	CcSEcCtD
Ethinyl Estradiol—Weight increased—Mitoxantrone—lymphatic system cancer	0.000781	0.00382	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000776	0.0038	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000775	0.00379	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00077	0.00377	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00077	0.00377	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Teniposide—lymphatic system cancer	0.000769	0.00376	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000763	0.00373	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000754	0.00369	CcSEcCtD
Ethinyl Estradiol—Nausea—Mechlorethamine—lymphatic system cancer	0.000752	0.00368	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00075	0.00367	CcSEcCtD
Ethinyl Estradiol—Alopecia—Bleomycin—lymphatic system cancer	0.000748	0.00366	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.000744	0.00364	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Carmustine—lymphatic system cancer	0.000743	0.00363	CcSEcCtD
Ethinyl Estradiol—Urticaria—Teniposide—lymphatic system cancer	0.000741	0.00363	CcSEcCtD
Ethinyl Estradiol—Herpes simplex—Methotrexate—lymphatic system cancer	0.00074	0.00362	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Carmustine—lymphatic system cancer	0.000739	0.00361	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Teniposide—lymphatic system cancer	0.000738	0.00361	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Teniposide—lymphatic system cancer	0.000738	0.00361	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000735	0.0036	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000726	0.00355	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000718	0.00351	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Carmustine—lymphatic system cancer	0.000712	0.00348	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000708	0.00346	CcSEcCtD
Ethinyl Estradiol—Fatigue—Fludarabine—lymphatic system cancer	0.000707	0.00346	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000702	0.00343	CcSEcCtD
Ethinyl Estradiol—Constipation—Fludarabine—lymphatic system cancer	0.000701	0.00343	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000697	0.00341	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000693	0.00339	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Vincristine—lymphatic system cancer	0.000691	0.00338	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Carmustine—lymphatic system cancer	0.000691	0.00338	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00069	0.00338	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000689	0.00337	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Teniposide—lymphatic system cancer	0.000688	0.00336	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000687	0.00336	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000684	0.00334	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000682	0.00333	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000682	0.00333	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000676	0.00331	CcSEcCtD
Ethinyl Estradiol—Asthenia—Teniposide—lymphatic system cancer	0.00067	0.00327	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000666	0.00326	CcSEcCtD
Ethinyl Estradiol—Malaise—Bleomycin—lymphatic system cancer	0.000665	0.00325	CcSEcCtD
Ethinyl Estradiol—Pruritus—Teniposide—lymphatic system cancer	0.00066	0.00323	CcSEcCtD
Ethinyl Estradiol—Cystitis—Methotrexate—lymphatic system cancer	0.000658	0.00322	CcSEcCtD
Ethinyl Estradiol—Alopecia—Carmustine—lymphatic system cancer	0.000653	0.00319	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Fludarabine—lymphatic system cancer	0.000648	0.00317	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Carmustine—lymphatic system cancer	0.000647	0.00317	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Methotrexate—lymphatic system cancer	0.000643	0.00315	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Carmustine—lymphatic system cancer	0.000643	0.00315	CcSEcCtD
Ethinyl Estradiol—Cough—Bleomycin—lymphatic system cancer	0.000643	0.00314	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Vincristine—lymphatic system cancer	0.00064	0.00313	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Teniposide—lymphatic system cancer	0.000639	0.00312	CcSEcCtD
Ethinyl Estradiol—Alopecia—Vincristine—lymphatic system cancer	0.000623	0.00305	CcSEcCtD
Ethinyl Estradiol—Back pain—Carmustine—lymphatic system cancer	0.000622	0.00304	CcSEcCtD
Ethinyl Estradiol—Discomfort—Bleomycin—lymphatic system cancer	0.00062	0.00303	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Vincristine—lymphatic system cancer	0.000618	0.00302	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Methotrexate—lymphatic system cancer	0.000616	0.00301	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Methotrexate—lymphatic system cancer	0.000616	0.00301	CcSEcCtD
Ethinyl Estradiol—Alopecia—Mitoxantrone—lymphatic system cancer	0.000607	0.00297	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000604	0.00296	CcSEcCtD
Ethinyl Estradiol—Oedema—Bleomycin—lymphatic system cancer	0.000601	0.00294	CcSEcCtD
Ethinyl Estradiol—Infection—Bleomycin—lymphatic system cancer	0.000597	0.00292	CcSEcCtD
Ethinyl Estradiol—Back pain—Vincristine—lymphatic system cancer	0.000594	0.0029	CcSEcCtD
Ethinyl Estradiol—Vomiting—Teniposide—lymphatic system cancer	0.000593	0.0029	CcSEcCtD
Ethinyl Estradiol—Asthenia—Fludarabine—lymphatic system cancer	0.000589	0.00288	CcSEcCtD
Ethinyl Estradiol—Rash—Teniposide—lymphatic system cancer	0.000588	0.00288	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Teniposide—lymphatic system cancer	0.000588	0.00287	CcSEcCtD
Ethinyl Estradiol—Headache—Teniposide—lymphatic system cancer	0.000585	0.00286	CcSEcCtD
Ethinyl Estradiol—Pruritus—Fludarabine—lymphatic system cancer	0.00058	0.00284	CcSEcCtD
Ethinyl Estradiol—Back pain—Mitoxantrone—lymphatic system cancer	0.000578	0.00283	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000561	0.00274	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000555	0.00271	CcSEcCtD
Ethinyl Estradiol—Nausea—Teniposide—lymphatic system cancer	0.000554	0.00271	CcSEcCtD
Ethinyl Estradiol—Anxiety—Carmustine—lymphatic system cancer	0.000546	0.00267	CcSEcCtD
Ethinyl Estradiol—Malaise—Mitoxantrone—lymphatic system cancer	0.000539	0.00264	CcSEcCtD
Ethinyl Estradiol—Oedema—Carmustine—lymphatic system cancer	0.000525	0.00257	CcSEcCtD
Ethinyl Estradiol—Visual disturbance—Methotrexate—lymphatic system cancer	0.000522	0.00255	CcSEcCtD
Ethinyl Estradiol—Cough—Mitoxantrone—lymphatic system cancer	0.000522	0.00255	CcSEcCtD
Ethinyl Estradiol—Infection—Carmustine—lymphatic system cancer	0.000522	0.00255	CcSEcCtD
Ethinyl Estradiol—Vomiting—Fludarabine—lymphatic system cancer	0.000522	0.00255	CcSEcCtD
Ethinyl Estradiol—Rash—Fludarabine—lymphatic system cancer	0.000517	0.00253	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Fludarabine—lymphatic system cancer	0.000517	0.00253	CcSEcCtD
Ethinyl Estradiol—Headache—Fludarabine—lymphatic system cancer	0.000514	0.00251	CcSEcCtD
Ethinyl Estradiol—Anxiety—Mitoxantrone—lymphatic system cancer	0.000507	0.00248	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000505	0.00247	CcSEcCtD
Ethinyl Estradiol—Discomfort—Mitoxantrone—lymphatic system cancer	0.000503	0.00246	CcSEcCtD
Ethinyl Estradiol—Oedema—Vincristine—lymphatic system cancer	0.000501	0.00245	CcSEcCtD
Ethinyl Estradiol—Infection—Vincristine—lymphatic system cancer	0.000498	0.00243	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000496	0.00242	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Vincristine—lymphatic system cancer	0.000491	0.0024	CcSEcCtD
Ethinyl Estradiol—Oedema—Mitoxantrone—lymphatic system cancer	0.000488	0.00239	CcSEcCtD
Ethinyl Estradiol—Nausea—Fludarabine—lymphatic system cancer	0.000487	0.00238	CcSEcCtD
Ethinyl Estradiol—Infection—Mitoxantrone—lymphatic system cancer	0.000485	0.00237	CcSEcCtD
Ethinyl Estradiol—Urticaria—Bleomycin—lymphatic system cancer	0.000478	0.00234	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Bleomycin—lymphatic system cancer	0.000475	0.00232	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000474	0.00232	CcSEcCtD
Ethinyl Estradiol—Irritability—Methotrexate—lymphatic system cancer	0.000472	0.00231	CcSEcCtD
Ethinyl Estradiol—Mood swings—Methotrexate—lymphatic system cancer	0.000469	0.00229	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000453	0.00222	CcSEcCtD
Ethinyl Estradiol—Constipation—Carmustine—lymphatic system cancer	0.000449	0.0022	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Methotrexate—lymphatic system cancer	0.000447	0.00219	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000443	0.00217	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000433	0.00212	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000433	0.00212	CcSEcCtD
Ethinyl Estradiol—Fatigue—Vincristine—lymphatic system cancer	0.000432	0.00211	CcSEcCtD
Ethinyl Estradiol—Asthenia—Bleomycin—lymphatic system cancer	0.000432	0.00211	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000429	0.0021	CcSEcCtD
Ethinyl Estradiol—Constipation—Vincristine—lymphatic system cancer	0.000429	0.0021	CcSEcCtD
Ethinyl Estradiol—Pruritus—Bleomycin—lymphatic system cancer	0.000426	0.00208	CcSEcCtD
Ethinyl Estradiol—Fatigue—Mitoxantrone—lymphatic system cancer	0.000421	0.00206	CcSEcCtD
Ethinyl Estradiol—Constipation—Mitoxantrone—lymphatic system cancer	0.000417	0.00204	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Carmustine—lymphatic system cancer	0.000415	0.00203	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Carmustine—lymphatic system cancer	0.000415	0.00203	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00041	0.002	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000402	0.00197	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—lymphatic system cancer	0.0004	0.00196	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000399	0.00195	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000397	0.00194	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Vincristine—lymphatic system cancer	0.000396	0.00194	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Vincristine—lymphatic system cancer	0.000396	0.00194	CcSEcCtD
Ethinyl Estradiol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000388	0.0019	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000387	0.00189	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000386	0.00189	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000386	0.00189	CcSEcCtD
Ethinyl Estradiol—Vomiting—Bleomycin—lymphatic system cancer	0.000382	0.00187	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—lymphatic system cancer	0.000381	0.00186	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—lymphatic system cancer	0.000381	0.00186	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—lymphatic system cancer	0.00038	0.00186	CcSEcCtD
Ethinyl Estradiol—Rash—Bleomycin—lymphatic system cancer	0.000379	0.00185	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Bleomycin—lymphatic system cancer	0.000379	0.00185	CcSEcCtD
Ethinyl Estradiol—Asthenia—Carmustine—lymphatic system cancer	0.000377	0.00184	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000369	0.00181	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00036	0.00176	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vincristine—lymphatic system cancer	0.00036	0.00176	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Carmustine—lymphatic system cancer	0.000359	0.00176	CcSEcCtD
Ethinyl Estradiol—Nausea—Bleomycin—lymphatic system cancer	0.000357	0.00175	CcSEcCtD
Ethinyl Estradiol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00035	0.00171	CcSEcCtD
Ethinyl Estradiol—Dizziness—Carmustine—lymphatic system cancer	0.000347	0.0017	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000344	0.00168	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Vincristine—lymphatic system cancer	0.000343	0.00168	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000342	0.00167	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—lymphatic system cancer	0.00034	0.00166	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000338	0.00165	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—lymphatic system cancer	0.000336	0.00164	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000334	0.00163	CcSEcCtD
Ethinyl Estradiol—Vomiting—Carmustine—lymphatic system cancer	0.000334	0.00163	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vincristine—lymphatic system cancer	0.000331	0.00162	CcSEcCtD
Ethinyl Estradiol—Rash—Carmustine—lymphatic system cancer	0.000331	0.00162	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Carmustine—lymphatic system cancer	0.000331	0.00162	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—lymphatic system cancer	0.00033	0.00161	CcSEcCtD
Ethinyl Estradiol—Headache—Carmustine—lymphatic system cancer	0.000329	0.00161	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000324	0.00158	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—lymphatic system cancer	0.00032	0.00156	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vincristine—lymphatic system cancer	0.000319	0.00156	CcSEcCtD
Ethinyl Estradiol—Rash—Vincristine—lymphatic system cancer	0.000316	0.00155	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vincristine—lymphatic system cancer	0.000316	0.00154	CcSEcCtD
Ethinyl Estradiol—Headache—Vincristine—lymphatic system cancer	0.000314	0.00154	CcSEcCtD
Ethinyl Estradiol—Nausea—Carmustine—lymphatic system cancer	0.000312	0.00152	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—lymphatic system cancer	0.000311	0.00152	CcSEcCtD
Ethinyl Estradiol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00031	0.00152	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—lymphatic system cancer	0.000309	0.00151	CcSEcCtD
Ethinyl Estradiol—Rash—Mitoxantrone—lymphatic system cancer	0.000308	0.0015	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000307	0.0015	CcSEcCtD
Ethinyl Estradiol—Headache—Mitoxantrone—lymphatic system cancer	0.000306	0.0015	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—lymphatic system cancer	0.000302	0.00148	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—lymphatic system cancer	0.0003	0.00147	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—lymphatic system cancer	0.000298	0.00146	CcSEcCtD
Ethinyl Estradiol—Nausea—Vincristine—lymphatic system cancer	0.000298	0.00146	CcSEcCtD
Ethinyl Estradiol—Nausea—Mitoxantrone—lymphatic system cancer	0.00029	0.00142	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—lymphatic system cancer	0.000288	0.00141	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000276	0.00135	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—lymphatic system cancer	0.000269	0.00131	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—lymphatic system cancer	0.00026	0.00127	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000252	0.00123	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—lymphatic system cancer	0.000251	0.00123	CcSEcCtD
Ethinyl Estradiol—Infection—Methotrexate—lymphatic system cancer	0.000242	0.00118	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000238	0.00117	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—lymphatic system cancer	0.000236	0.00115	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00021	0.00103	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—lymphatic system cancer	0.00021	0.00103	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0002	0.00098	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000199	0.000972	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methotrexate—lymphatic system cancer	0.000193	0.000945	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000192	0.00094	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000192	0.00094	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000179	0.000876	CcSEcCtD
Ethinyl Estradiol—Asthenia—Methotrexate—lymphatic system cancer	0.000174	0.000853	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—lymphatic system cancer	0.000172	0.000841	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000166	0.000814	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methotrexate—lymphatic system cancer	0.000161	0.000786	CcSEcCtD
Ethinyl Estradiol—Vomiting—Methotrexate—lymphatic system cancer	0.000155	0.000756	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—lymphatic system cancer	0.000153	0.00075	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—lymphatic system cancer	0.000153	0.000749	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—lymphatic system cancer	0.000152	0.000745	CcSEcCtD
Ethinyl Estradiol—Nausea—Methotrexate—lymphatic system cancer	0.000144	0.000706	CcSEcCtD
